Eagle Pharmaceuticals
EGRX
$4.41
Share price
0.23%
Change (1 day)
-84.46%
Change (1 year)
Categories
Earnings for Eagle Pharmaceuticals (EGRX)
Earnings in 2023 (TTM): $35.65 M
According to Eagle Pharmaceuticals 's latest financial reports the company's current earnings (TTM) are $35.65 M. In 2022 the company made an earning of $65.87 M an increase over its 2021 earnings that were of -$2.92 M.The earnings displayed on this page is the company's Pretax Income.
Earnings history for Eagle Pharmaceuticals from 2013 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2023 (TTM)  | $35.65 M | -45.87% |
| 2022 | $65.87 M | -2361.45% |
| 2021 | -$2.92 M | -111.53% |
| 2020 | $25.25 M | 2.31% |
| 2019 | $24.68 M | -32.89% |
| 2018 | $36.77 M | -50.35% |
| 2017 | $74.08 M | 38.63% |
| 2016 | $53.43 M | 1966.43% |
| 2015 | $2.58 M | -111.46% |
| 2014 | -$22.58 M | 282.82% |
| 2013 | -$5.9 M |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $16.97 B | 47,495.28% | 🇺🇸 USA |
 Novartis NVS | $9.82 B | 27,458.26% | 🇨🇭 Switzerland |
 Eli Lilly LLY | $6.55 B | 18,281.33% | 🇺🇸 USA |
 Amgen AMGN | $7.85 B | 21,928.10% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | -$5.85 B | -16,494.18% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $7.53 B | 21,030.77% | 🇬🇧 UK |
 Teva Pharmaceutical Industries TEVA | $0.40 B | 1,035.76% | 🇮🇱 Israel |